Weight variation gain and chemotherapy in women having breast cancer treated in the public health system
The aim of this study was to evaluate the influence of chemotherapy on weight change in women having breast cancer treated at a public hospital in Goiânia-GO. This is a descriptive retrospective study analyzing the medical records of women from 34 to 80 years old who met the inclusion criteria. The...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centro Universitário São Camilo
2014-07-01
|
| Series: | O Mundo da Saúde |
| Subjects: | |
| Online Access: | https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/367 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823858191917645824 |
|---|---|
| author | Samira Obeid Georges Cinthya Costa Braga Karine Anusca Martins |
| author_facet | Samira Obeid Georges Cinthya Costa Braga Karine Anusca Martins |
| author_sort | Samira Obeid Georges |
| collection | DOAJ |
| description | The aim of this study was to evaluate the influence of chemotherapy on weight change in women having breast cancer
treated at a public hospital in Goiânia-GO. This is a descriptive retrospective study analyzing the medical records of women
from 34 to 80 years old who met the inclusion criteria. The sample was classified as a convenience one, and met the
demand of the service. A questionnaire was used to obtain personal identification data, social-demographic data, and anthropometric
data as well as general health status. For the 30 study participants body mass index (BMI) was similar before
chemotherapy (27.45 ± 5.42 kg/m2) and after (27.53 ± 5.71 kg/m2) and placed the sample in the overweight category (BMI:
25.00 to 29.99 kg/m2). Most patients were submitted to neoadjuvant treatment, being adriblastine + cyclophosphamide
(AC) associated with carboplatin + paclitaxel (Taxol) the most frequent combination (80.0%). Most of the sample subjects
were overweight or obese before and after chemotherapy. Although there was weight variations due to chemotherapy protocols,
no influence of chemotherapy on the nutritional status of the women in the study was identified. |
| format | Article |
| id | doaj-art-5151f2cbaa5d4f9b98331f0fd3f7fcb0 |
| institution | Kabale University |
| issn | 0104-7809 1980-3990 |
| language | English |
| publishDate | 2014-07-01 |
| publisher | Centro Universitário São Camilo |
| record_format | Article |
| series | O Mundo da Saúde |
| spelling | doaj-art-5151f2cbaa5d4f9b98331f0fd3f7fcb02025-02-11T13:32:53ZengCentro Universitário São CamiloO Mundo da Saúde0104-78091980-39902014-07-01383260268307Weight variation gain and chemotherapy in women having breast cancer treated in the public health systemSamira Obeid Georges0Cinthya Costa Braga1Karine Anusca Martins2Faculdade de Nutrição, Universidade Federal de Goiás, Goiânia-GO, Brasil.Hospital das Clínicas da Universidade Federal de Goiás, Goiânia-GO, Brasil.Faculdade de Nutrição, Universidade Federal de Goiás, Goiânia-GO, BrasilThe aim of this study was to evaluate the influence of chemotherapy on weight change in women having breast cancer treated at a public hospital in Goiânia-GO. This is a descriptive retrospective study analyzing the medical records of women from 34 to 80 years old who met the inclusion criteria. The sample was classified as a convenience one, and met the demand of the service. A questionnaire was used to obtain personal identification data, social-demographic data, and anthropometric data as well as general health status. For the 30 study participants body mass index (BMI) was similar before chemotherapy (27.45 ± 5.42 kg/m2) and after (27.53 ± 5.71 kg/m2) and placed the sample in the overweight category (BMI: 25.00 to 29.99 kg/m2). Most patients were submitted to neoadjuvant treatment, being adriblastine + cyclophosphamide (AC) associated with carboplatin + paclitaxel (Taxol) the most frequent combination (80.0%). Most of the sample subjects were overweight or obese before and after chemotherapy. Although there was weight variations due to chemotherapy protocols, no influence of chemotherapy on the nutritional status of the women in the study was identified.https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/367breast neoplasms. nutritional status. weight gain. drug therapy. |
| spellingShingle | Samira Obeid Georges Cinthya Costa Braga Karine Anusca Martins Weight variation gain and chemotherapy in women having breast cancer treated in the public health system O Mundo da Saúde breast neoplasms. nutritional status. weight gain. drug therapy. |
| title | Weight variation gain and chemotherapy in women having breast cancer treated in the public health system |
| title_full | Weight variation gain and chemotherapy in women having breast cancer treated in the public health system |
| title_fullStr | Weight variation gain and chemotherapy in women having breast cancer treated in the public health system |
| title_full_unstemmed | Weight variation gain and chemotherapy in women having breast cancer treated in the public health system |
| title_short | Weight variation gain and chemotherapy in women having breast cancer treated in the public health system |
| title_sort | weight variation gain and chemotherapy in women having breast cancer treated in the public health system |
| topic | breast neoplasms. nutritional status. weight gain. drug therapy. |
| url | https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/367 |
| work_keys_str_mv | AT samiraobeidgeorges weightvariationgainandchemotherapyinwomenhavingbreastcancertreatedinthepublichealthsystem AT cinthyacostabraga weightvariationgainandchemotherapyinwomenhavingbreastcancertreatedinthepublichealthsystem AT karineanuscamartins weightvariationgainandchemotherapyinwomenhavingbreastcancertreatedinthepublichealthsystem |